Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 316,008
  • Shares Outstanding, K 102,600
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,410 K
  • 36-Month Beta 1.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.05 +2.62%
on 07/19/18
3.58 -12.57%
on 07/13/18
-0.27 (-7.94%)
since 06/19/18
3-Month
2.46 +27.24%
on 04/20/18
3.98 -21.36%
on 05/31/18
+0.59 (+23.23%)
since 04/19/18
52-Week
2.18 +43.58%
on 04/04/18
4.51 -30.60%
on 12/01/17
+0.20 (+6.83%)
since 07/19/17

Most Recent Stories

More News
Free Research Reports on Catalent and Three More Generic Drugs Stocks

Stock Research Monitor: CPRX, COLL, and DPLO

COLL : 19.65 (+0.56%)
CTLT : 43.41 (+0.53%)
CPRX : 3.15 (+2.27%)
Innovative Biotech Companies, Preparing for the Future

LAS VEGAS, NV / ACCESSWIRE / June 15, 2018 / Some innovative biotechnology companies that are working on ground-breaking technology and are prepared for the future include: Propanc Biopharma, Inc. (OTCQB:...

CLDX : 0.52 (+1.96%)
PPCHD : 1.2000 (+20.00%)
AQXP : 2.94 (+1.03%)
PPCB : 0.0280 (-11.95%)
CPRX : 3.15 (+2.27%)
Catalyst Pharmaceuticals Appoints Daniel J. Brennan as Chief Commercial Officer

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.15 (+2.27%)
Opiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors

Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced the appointment of Richard J. Daly as a non-executive...

CUR : 1.16 (-3.25%)
OPNT : 14.33 (-0.14%)
CPRX : 3.15 (+2.27%)
Catalyst's Fridapse Gets Priority Review by FDA, Shares Up

The FDA grants Priority Review to Catalyst's (CPRX) lead pipeline candidate, Firdapse, and set an action date of Nov 28, 2018.

LGND : 230.81 (+1.80%)
ILMN : 309.27 (+0.65%)
BMRN : 102.43 (-0.25%)
CPRX : 3.15 (+2.27%)
Catalyst Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.15 (+2.27%)
Catalyst (CPRX) Posts In-Line Q1 Loss, Pipeline Progresses

Catalyst reported in-line loss in Q1. The company resubmitted a new drug application for its lead candidate Firdapse and expects FDA to accept the NDA in Q2.

LGND : 230.81 (+1.80%)
CATB : 0.76 (-1.30%)
ENTA : 125.21 (-0.31%)
CPRX : 3.15 (+2.27%)
Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological...

CPRX : 3.15 (+2.27%)
What's in Store for Catalyst (CPRX) This Earnings Season?

Catalyst (CPRX) is expected to report first-quarter 2018 results on May 9, after the market closesa and investor's focus will be on pipeline and regulatory updates during the earnings call.

CELG : 85.50 (-0.33%)
ADVM : 5.03 (+1.62%)
EBS : 54.29 (-0.80%)
CPRX : 3.15 (+2.27%)
Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 2018

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.15 (+2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CPRX with:

Business Summary

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for...

See More

Key Turning Points

2nd Resistance Point 3.18
1st Resistance Point 3.13
Last Price 3.15
1st Support Level 3.05
2nd Support Level 3.02

See More

52-Week High 4.51
Fibonacci 61.8% 3.62
Fibonacci 50% 3.35
Last Price 3.15
Fibonacci 38.2% 3.07
52-Week Low 2.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar